Keywords: Enterologics, Prescription probiotics, Gastrointestinal disorders, USA

Enterologics aims to produce Rx biotherapeutics for GI diseases

Article | 05 June 2012

USA-based biotech firm Enterologics (OTCBB: ELGO.OB), which is focussed on the development of live biotherapeutic products for gastrointestinal (GI) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Enterologics

Go to company listing